The Build Back Better Act continues to be a work in progress, but a recent version passed by the House of Representatives gives seniors a reason to cheer.
For as long as the Medicare Part D prescription drug plan has existed, beneficiaries have struggled with out-of-pocket costs. Now, movement on Capitol Hill suggests this may finally be the year for reform.
Just as states started banning abusive co-pay accumulator programs, insurers have found a work-around that once again could put patients at a disadvantage when it comes to out-of-pocket prescription drug costs.
The holiday season is synonymous with sending and receiving cards. But there’s one card many seniors won’t have in hand this holiday: a co-pay card.
The growing threat of coronavirus demands that people get tested if they show flu-like symptoms. Yet some Americans may find it hard to pay for a doctor’s visit, lab testing and treatment.
After spending time and money to see a dermatologist, many patients with acne fail to fill their prescription. Cost sharing is the culprit, according to a recently published study.
Are coupons that help patients afford their co-pays a help – or a hindrance – in the age of innovative but costly prescription medications? A new “Co-Pay Coupons” Fast Facts from the Institute for Patient Access explores why coupons and co-pay assistance programs remain a source of debate – and how they impact patients’ ability to access the medication their doctor prescribes.
Some Medicare beneficiaries pay 20 percent of their income in out-of-pocket medical expenses, a new study finds.
Senior citizens can face crippling out-of-pocket costs for their Medicare Part D prescription drugs. But now the University of Pennsylvania’s Perelman School of Medicine has proposed an intriguing solution inspired by an unexpected source: the utility companies.
Patients diagnosed with debilitating conditions often struggle to pay the high deductibles required for their health plans to begin covering treatment. Now, a product designed by insurers to fill the gap for these patients is on the rise.